Cryopreservation of Cells: Basic Protocol and Best Practices

Cryopreservation is the process of cooling living cells to ultra-low temperature — typically storage in liquid nitrogen at or below -135°C — so that metabolic activity, and with it genetic drift, contamination risk, and simple attrition, effectively stops. A well-run cryopreservation program is what lets a lab keep a hard-won cell line, a patient-derived primary culture, or a validated clone alive indefinitely without continuous passaging, and recover it years later at close to the viability it had the day it was frozen. Done poorly — wrong cooling rate, too much time at room temperature in cryoprotectant, a slow thaw — it is also one of the most common ways labs lose irreplaceable material. This guide walks through the biology of why freezing damages cells, a standard step-by-step protocol, the tradeoffs between freezing methods, and the mistakes that most often cost viability.

Why Cells Need a Deliberate Freezing Protocol

Every actively growing culture accumulates passage-number drift: genetic and phenotypic changes, gradual loss of differentiation potential in stem cell lines, and rising risk of mycoplasma or cross-contamination the longer cells stay in continuous culture. Cryopreservation lets a lab bank a low-passage master stock and a working stock, so a contaminated or drifted culture can be discarded and replaced from frozen material instead of restarting from scratch — or, for primary cells and patient samples, instead of being unrecoverable altogether. Biobanks, core facilities, and any lab maintaining reference cell lines rely on the same underlying protocol described below, scaled to the number of vials involved.

The Physics Problem: Ice Formation and Osmotic Stress

Water inside and around a cell does not freeze gently. As temperature drops, ice crystals first form in the extracellular fluid, which concentrates the solutes left in the remaining unfrozen water outside the cell. That concentration gradient pulls water out of the cell osmotically. Cool too slowly and the cell dehydrates severely before it ever freezes, damaging membranes and organelles through prolonged osmotic stress. Cool too quickly and there isn’t time for water to leave the cell before the temperature drops past its freezing point, so ice crystals form inside the cell instead — intracellular ice is lethal, rupturing membranes and organelles directly. Cryopreservation protocols exist to hit the narrow middle ground: slow enough to let water exit the cell, fast enough to limit total dehydration time. That is the entire rationale behind the standard -1°C-per-minute cooling rate used across mammalian cell cryopreservation.

Cryoprotectants: DMSO, Glycerol, and Alternatives

A cryoprotectant agent (CPA) lowers the freezing point of the solution and reduces the concentration of damaging solutes the cell is exposed to during freezing, buying time for the cell to equilibrate osmotically before ice fully forms.

• DMSO (dimethyl sulfoxide) is the most widely used cryoprotectant for mammalian cell lines, typically used at a final concentration of 5-10% v/v (10% is the most common default) in a freezing medium of complete growth medium or serum, often with added serum (commonly around 90% FBS + 10% DMSO for many standard lines, though the exact ratio depends on the cell type). DMSO penetrates the cell membrane readily, which is what makes it effective, but it is also cytotoxic at room temperature — cells should not sit in DMSO-containing freezing medium at room temperature for more than a few minutes before cooling begins.
• Glycerol is a slower-penetrating alternative, more commonly used for some primary cells and in reproductive cell freezing, generally at higher concentrations (10-20%) because it equilibrates less efficiently than DMSO.
• Serum-free and DMSO-free cryopreservation media (commercial formulations built around alternative CPAs, or lower-DMSO formulations) exist for cell therapy and clinical manufacturing contexts where DMSO’s toxicity on infusion, or serum’s regulatory and lot-to-lot variability, is a problem. These typically cost more per vial and are chosen when the frozen product is destined for a patient or a GMP process rather than routine lab stock.

Step-by-Step Cell Cryopreservation Protocol

1. Assess culture health before freezing. Freeze cells at 70-90% confluency (or mid-log phase for suspension cultures) from a healthy, mycoplasma-free, low-passage culture. Freezing an unhealthy or over-confluent culture banks that condition into every future recovery.
2. Harvest and count. Detach adherent cells (trypsin/EDTA or a non-enzymatic dissociation reagent, depending on the line) and count viable cells, typically with a hemocytometer and trypan blue exclusion or an automated counter. Most protocols target a specific cell density per vial (often in the range of 1-5 x 10^6 cells/mL, but the correct density is cell-type- and downstream-use-specific) rather than a fixed cell number, since recovery efficiency depends on density.
3. Prepare freezing medium. Make up complete growth medium (or serum) with cryoprotectant — most often 10% DMSO — fresh, and keep it cold until use. Some protocols add DMSO to the cell suspension in two steps to reduce the time cells spend at the final CPA concentration before cooling starts.
4. Resuspend and aliquot. Gently resuspend the pelleted cells in cold freezing medium and aliquot promptly into labeled cryovials — label with cell line, passage number, date, and operator before freezing, not after, since labels applied to a frost-covered vial later are unreliable. Work quickly here: total time in DMSO-containing medium at room temperature should stay under roughly 15-20 minutes.
5. Cool at a controlled rate. Transfer vials immediately to a device that cools at approximately -1°C/minute (see the comparison below) and place that device at -80°C for at least 2-4 hours, or overnight.
6. Move to long-term storage. Transfer vials from the -80°C freezer to liquid nitrogen (vapor or liquid phase) within 24-48 hours. Cells left at -80°C for weeks to months will show progressively worse post-thaw viability — -80°C is a transit temperature for controlled cooling, not a long-term archive.

Controlled-Rate Freezing Methods Compared

All of these methods aim to approximate the same -1°C/minute cooling curve; they differ in cost, reproducibility, and vial capacity.

• Isopropanol freezing containers (the genericized “Mr. Frosty” being the best-known commercial version) use isopropyl alcohol surrounding a vial rack inside an insulated container; placed directly in a -80°C freezer, the isopropanol jacket slows heat loss to approximately -1°C/minute. Low cost, no power required, and adequate for most routine lab freezing, but the isopropanol needs periodic replacement (manufacturers typically specify after a set number of uses) as its cooling performance degrades with repeated freeze-thaw cycling.
• Cryoprotectant-free foam or bead-based coolers (some sold as reusable alternatives to alcohol-based containers) work on a similar passive-insulation principle without the isopropanol.
• Programmable (controlled-rate) freezers use a linear-cooling algorithm and liquid nitrogen injection to hold a precise, programmable rate through the critical latent-heat-of-fusion phase transition, rather than approximating it passively. These are standard in cell therapy manufacturing, biobanking, and any process where batch-to-batch reproducibility is a validated requirement, and can handle far larger vial counts per run than a passive container.

Long-Term Storage: Vapor Phase vs. Liquid Phase Liquid Nitrogen

Liquid nitrogen boils at -196°C at atmospheric pressure. A cryogenic storage dewar holds a pool of liquid nitrogen at the bottom, with a cold nitrogen vapor layer above it; vials can be racked either submerged in the liquid phase or suspended in the vapor phase above it.

• Vapor phase storage (typically -135°C to -190°C depending on rack height above the liquid) is now the more common choice for most labs, because it eliminates the risk of liquid nitrogen wicking into an imperfectly sealed cryovial through a compromised O-ring or hairline crack. A vial that takes up liquid nitrogen in storage can, on rapid warming during thaw, flash the trapped liquid to gas explosively — a real safety hazard, not just a sample-integrity one.
• Liquid phase storage holds a more stable, uniform temperature and is less sensitive to how full the dewar is, but carries the vial-explosion risk above and is generally reserved for cases where a lab specifically wants the most stable possible archival temperature and uses cryovials rated and tested for full liquid immersion.

The generally cited threshold for stable long-term biological storage is below roughly -130°C to -135°C, the glass transition temperature of the residual unfrozen fraction in a typical cryopreserved sample — below this point, molecular mobility (and therefore ongoing degradation) is considered negligible on any practically relevant timescale. This is the reason -80°C mechanical freezers are treated as short-term (weeks-to-months) storage rather than an archival substitute for liquid nitrogen.

Thawing Cryopreserved Cells Correctly

Thawing is the inverse problem of freezing, and just as failure-prone: cells need to move through the ice-crystal danger zone quickly on the way back up, and the cryoprotectant that protected them while frozen becomes cytotoxic again the moment it’s back at physiological temperature.

1. Retrieve the vial and thaw it rapidly, typically by gentle agitation in a 37°C water bath (or bead bath) until just a small ice pellet remains — generally under 2 minutes for a standard 1-2 mL cryovial. Slow, room-temperature thawing re-exposes cells to the same damaging ice-recrystallization window they passed through on the way down.
2. Wipe the vial exterior (water baths are a contamination vector) and transfer the cell suspension dropwise into several volumes of pre-warmed complete medium to dilute the DMSO quickly.
3. Centrifuge gently, aspirate the DMSO-containing supernatant, and resuspend the pellet in fresh medium before plating — this removes residual DMSO rather than leaving cells to grow it out, which is gentler on sensitive lines. Some robust immortalized lines tolerate a direct dilution-and-plate approach without a centrifugation step; primary and sensitive cells generally do not.
4. Assess viability (trypan blue exclusion or an equivalent live/dead assay) immediately after thaw, and again 24 hours later once cells have had a chance to recover and re-adhere — the immediate post-thaw count and the 24-hour recovery count can differ meaningfully.

Common Mistakes That Reduce Post-Thaw Viability

• Freezing sick or over-confluent cultures. Freezing does not improve a culture’s condition; it locks it in.
• Leaving cells in DMSO-containing medium too long before cooling starts. Every extra minute at room temperature in freezing medium is cytotoxic exposure time.
• Skipping the -80°C controlled-cooling step and placing vials directly into liquid nitrogen. This drives cooling far faster than -1°C/minute and drives intracellular ice formation.
• Leaving vials at -80°C for extended periods instead of promptly moving them to liquid nitrogen, allowing slow ice recrystallization damage to accumulate over weeks.
• Thawing slowly instead of rapidly in a 37°C bath, or letting a vial sit at room temperature before diluting out the DMSO.
• Poor or missing labeling — a frost-covered, illegibly labeled vial pulled from a shared liquid nitrogen dewar years later is a recurring, entirely preventable cause of lost or misidentified stocks.
• Freezing only one stock. A single master stock with no backup vials, or vials all stored in a single dewar with no split across separate tanks/sites, turns an equipment failure into a total loss.

Assessing Post-Thaw Viability and Recovery

Viability immediately after thaw (trypan blue exclusion or a fluorescence-based live/dead assay) is a useful first check but not the full picture — a cell can exclude dye and still fail to attach, proliferate, or recover normal morphology and doubling time over the following days. A well-validated cryopreservation protocol for a given cell line should specify both an acceptable immediate post-thaw viability threshold and a recovery checkpoint (attachment by 24 hours, normal morphology and doubling time by the first passage after thaw) before that stock is considered qualified for use in downstream experiments. For labs that document these protocols formally, the general structure and format conventions in How to Write a Lab SOP: Step-by-Step Template and Guide apply directly to a cryopreservation SOP — freeze-down criteria, cooling method, storage location, and thaw/recovery acceptance criteria are exactly the kind of stepwise, criteria-driven procedure an SOP is meant to capture.

Frequently Asked Questions

How long can cells stay cryopreserved?

Cells stored properly in liquid nitrogen (vapor or liquid phase, below roughly -135°C) are generally considered stable for years to decades, since molecular activity at that temperature is negligible. In practice, viability loss over long-term liquid nitrogen storage is usually attributable to freeze-thaw handling quality at the time of freezing, not storage duration itself, provided the dewar’s temperature and nitrogen level are consistently maintained.

What’s the best cryoprotectant for freezing cells?

DMSO at 5-10% (v/v), most commonly 10%, is the default for the large majority of mammalian cell lines and is what most published protocols and commercial freezing media use. Glycerol or DMSO-free/serum-free formulations are used for specific cell types (some primary cells, reproductive cells) or for clinical/cell-therapy contexts where DMSO’s cytotoxicity on infusion into a patient is a concern.

Can you refreeze cells after they’ve been thawed?

Refreezing previously thawed cells is generally discouraged and, for most lines, produces measurably lower post-thaw viability on the second freeze-thaw cycle than the first. If a vial must be split or a culture re-banked, best practice is to expand the thawed culture back to a healthy state in continuous culture first, then freeze a fresh stock from that expanded, healthy population rather than directly refreezing leftover cell suspension.

Is DMSO dangerous to work with?

DMSO is toxic to cells at room temperature in the concentrations used for freezing, and it also readily penetrates skin and can carry other dissolved substances through it — standard chemical PPE (gloves rated for DMSO, eye protection) should be used when handling it, and spills should be treated as a chemical exposure, not a routine culture-medium spill.

What is the difference between vapor phase and liquid phase liquid nitrogen storage?

Vapor phase storage keeps vials in the cold nitrogen gas above the liquid nitrogen pool in a dewar, avoiding the risk of liquid nitrogen seeping into an imperfectly sealed vial and causing a violent flash-to-gas expansion on thaw. Liquid phase storage submerges vials directly in the liquid and offers a more uniform, stable temperature, but requires cryovials specifically rated for liquid immersion and carries that vial-integrity risk. Most modern lab and biobank storage defaults to vapor phase for this reason.